Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Patrick Hughes

Psychiatry Leawood, KS Medical Doctor

NPI 1598790909 CMS profile 27400

8700 State Line Rd Ste 310, Leawood, KS 66206

Open in the dashboard

General payments

$4,450

275 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Patrick Hughes of Leawood, KS is reported in the CMS Open Payments database as having received $4,450 across 275 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $1,077 58
2021 General $1,355 94
2020 General $1,057 60
2019 General $961 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick Hughes
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Patrick Hughes were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Patrick Hughes Psychiatry median Middle half National median
2019 $961 $184 $59–$605 $163
2020 $1,057 $119 $36–$372 $114
2021 $1,355 $143 $43–$576 $132
2022 $1,077 $153 $50–$590 $149
2023 $0 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Neurocrine Biosciences, Inc. $722 35 payments
  2. Otsuka America Pharmaceutical, Inc. $681 41 payments
  3. Lundbeck LLC $668 46 payments
  4. ITI, Inc. $504 30 payments
  5. AbbVie, Inc. $377 25 payments
  6. Teva Pharmaceuticals USA, Inc. $339 23 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $258 17 payments
  8. Vanda Pharmaceuticals Inc. $184 11 payments
  9. Janssen Pharmaceuticals, Inc $140 9 payments
  10. Bausch Health US, LLC $92 7 payments
  11. Other $485 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $4,450 275 payments
Products named General payments · program years 2019–2022
  1. REXULTI Psychiatry $681 41 payments
  2. CAPLYTA $504 30 payments
  3. REXULTI Psychiatry $470 34 payments
  4. VRAYLAR $377 25 payments
  5. INGREZZA Neurology $340 19 payments
  6. AUSTEDO $339 23 payments
  7. INGREZZA Neuropsychiatry $229 9 payments
  8. BRINTELLIX $198 12 payments
  9. FANAPT $184 11 payments
  10. HETLIOZ $167 10 payments
  11. Other $1,410 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

275 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record